In patients with intense pruritismay leadplasmapheresis
Aggressive treatment with immunosuppressive agents and/ormight leadplasmapheresis
to thin the blood that 's become thick with high levels of IGM antibodies(passive) is designedPlasmapheresis
rose to 1:16 on POD 2promptingplasmapheresis
to helppreventplasmapheresis
using serious(passive) was caused byplasmapheresis
Charles Drew eighty years ago in D.C. as a way of storing blood(passive) was invented byplasmapheresis
Wood WorkPainted291512043040000020
First you haveto discoverwwve
On POD 5 , the titer increased to 1:16promptingplasmapheresis
3 ) of the statutes(passive) is created645.05
as pilot symbolsto createEHCPC
in normalized platelet levels and continued clinical improvementresultingin normalized platelet levels and continued clinical improvement
in short - lived improvementresultedin short - lived improvement
the medial compartment , so highmay causethe medial compartment , so high
to short - term improvement of weaknessleadsto short - term improvement of weakness
to exchange Aβ - laden , oxidized albumin with clean proteindesignedto exchange Aβ - laden , oxidized albumin with clean protein
to an improvement in some LEMS patients who are experiencing an acute exacerbationcan leadto an improvement in some LEMS patients who are experiencing an acute exacerbation
in rapid improvement in cholestatic jaundice with resolution of AKIresultingin rapid improvement in cholestatic jaundice with resolution of AKI
to remission of refractory nephrotic syndrome due to fibrillary glomerulonephritis : a case reportRainer U Pliquett , Peter Mohr , Badr El Din Mukhtar , Matthias Girndt , Silke MarkauJournal of medical case reports2012INTRODUCTIONleadingto remission of refractory nephrotic syndrome due to fibrillary glomerulonephritis : a case reportRainer U Pliquett , Peter Mohr , Badr El Din Mukhtar , Matthias Girndt , Silke MarkauJournal of medical case reports2012INTRODUCTION
maximum improvement but this improvement again deteriorates once the body generates fresh antibodiescausesmaximum improvement but this improvement again deteriorates once the body generates fresh antibodies
in a slight improvement in activities of daily living lasting less than two weeksresultedin a slight improvement in activities of daily living lasting less than two weeks
in improved inflammation , resolution of exudative detachments and eventual improvement in vision after cataract surgery and continued survival 1 year after the diagnosis of BDUMPresultedin improved inflammation , resolution of exudative detachments and eventual improvement in vision after cataract surgery and continued survival 1 year after the diagnosis of BDUMP
in the significant improvement of abdominal pain along with a decrease in the serum TG level from > 5000 mg / L to 1000 mg / L.resultedin the significant improvement of abdominal pain along with a decrease in the serum TG level from > 5000 mg / L to 1000 mg / L.
a decrease in plasma cholinesterase levels that may prolong the effect of drugs such as succinylcholine that are normally broken down by this enzyme systemcausesa decrease in plasma cholinesterase levels that may prolong the effect of drugs such as succinylcholine that are normally broken down by this enzyme system
by decreasing sialylated IgGmay leadby decreasing sialylated IgG
excess bleeding intraoperatively due to coagulation factor depletion unless fresh frozen plasma ( FFP ) products are used in the replacement fluid mixmay causeexcess bleeding intraoperatively due to coagulation factor depletion unless fresh frozen plasma ( FFP ) products are used in the replacement fluid mix
in lymphocytosis and reappearance of a functionally intact helper T cell populationresultedin lymphocytosis and reappearance of a functionally intact helper T cell population
the laboratory analysis , venesectionmay resultthe laboratory analysis , venesection
to hypotensioncan leadto hypotension
non - steady state condition(passive) caused bynon - steady state condition
to complications including infection , reduction in platelets , hemoglobin and coagulation factorscan leadto complications including infection , reduction in platelets , hemoglobin and coagulation factors
to the normalization of blood propertiescontributesto the normalization of blood properties
the development of multiple organ failure [ Gorodin V.N. , 2003 ; Cerdas - Quesada C. , 2011also preventedthe development of multiple organ failure [ Gorodin V.N. , 2003 ; Cerdas - Quesada C. , 2011
the rapid progression of the disease so that additional therapy can be initiatedmay preventthe rapid progression of the disease so that additional therapy can be initiated
recurrence in neuromyelitis opticapreventsrecurrence in neuromyelitis optica
a rapid reduction of serumcauseda rapid reduction of serum
early IRIS with a high mortality rate and poor prognosis.8causingearly IRIS with a high mortality rate and poor prognosis.8
numbness in the fingers or around the mouth and nosemay also causenumbness in the fingers or around the mouth and nose
Nephrotic syndrome and plasmapheresis ... 01/01/1991ledNephrotic syndrome and plasmapheresis ... 01/01/1991
a significant reduction in serum IgMcauseda significant reduction in serum IgM
in pack , diuretics , long - acting beta2 agonistsresultingin pack , diuretics , long - acting beta2 agonists
circle travel - related sky pharmacy brothers pigment ... denervatedcausedcircle travel - related sky pharmacy brothers pigment ... denervated
to amelioration of symptoms and a significant decline in thyroid hormone levelsleadsto amelioration of symptoms and a significant decline in thyroid hormone levels
complications from hyperviscositycan preventcomplications from hyperviscosity
in a rapid decline of anti - GBM antibodies in the circulationwill resultin a rapid decline of anti - GBM antibodies in the circulation
in complete or partial remission in 75 % of those with recurrenceresultedin complete or partial remission in 75 % of those with recurrence
Execution(passive) is triggered byExecution
in significant reductions in serum IgMresultedin significant reductions in serum IgM